Contact
searchSearch
HMP Global

Drug Recalls Topic Center

The Latest

News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
Pfizer's Class II Recall for Epinephrine
08/27/2025
Danielle Sposato
Pfizer Inc. has voluntarily initiated a Class II recall of Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL) supplied in vials and distributed by its Hospira division. The recall affects 49,620 vials nationwide across the United States.
Pfizer Inc. has voluntarily initiated a Class II recall of Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL) supplied in vials and distributed by its Hospira division. The recall affects 49,620 vials nationwide across the United States.
Pfizer Inc. has voluntarily...
08/27/2025
Pharmacy Learning Network
News
FDA Recall Notice: BZK Antiseptic Towelettes
08/27/2025
Danielle Sposato
Taizhou Kangping Medical Science and Technology Co., Ltd. has voluntarily initiated a recall of its BZK Antiseptic Towelettes (benzalkonium chloride 0.13%), packaged as 100 sterile towelettes per carton and labeled for professional use. The...
Taizhou Kangping Medical Science and Technology Co., Ltd. has voluntarily initiated a recall of its BZK Antiseptic Towelettes (benzalkonium chloride 0.13%), packaged as 100 sterile towelettes per carton and labeled for professional use. The...
Taizhou Kangping Medical Science...
08/27/2025
Pharmacy Learning Network

Newsfeed

News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Class II Recall Issued for Doxepin Hydrochloride Capsules Due to Nitrosamine Impurity
08/13/2025
Juliet Gallagher
Alembic Pharmaceuticals Limited has voluntarily initiated a nationwide Class II recall of its doxepin hydrochloride capsules, USP, 10 mg.
Alembic Pharmaceuticals Limited has voluntarily initiated a nationwide Class II recall of its doxepin hydrochloride capsules, USP, 10 mg.
Alembic Pharmaceuticals Limited...
08/13/2025
Pharmacy Learning Network
News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use